Dillon & Associates’s Express Scripts Holding Company ESRX Stock Holding History
Bought
Maintained
Sold
Other funds holding ESRX
ECM
BJL
BSPF
MYAM
AWM
W
ACA
UCFA
SBL
Dillon & Associates's ESRX Position: Q4 2018 in Review
Dillon & Associates sold out of Express Scripts Holding Company (ESRX) in Q4 2018, closing a stake of 4,790 shares — an estimated $455K sold.
Dillon & Associates first reported a position in ESRX in Q4 2014 and held it in 16 quarters. The position peaked at $455K in Q3 2018. 16 funds tracked by Wall St. Rank hold ESRX as of Q4 2018.
- Dillon & Associates reported no remaining Express Scripts Holding Company position as of Q4 2018 after selling out during the quarter.
- Dillon & Associates sold 4,790 Express Scripts Holding Company shares in Q4 2018, an estimated $455K.
- Dillon & Associates first reported a position in Express Scripts Holding Company in Q4 2014 and held it in 16 quarters.
- Dillon & Associates's Express Scripts Holding Company position peaked at $455K in Q3 2018.
- 16 funds tracked by Wall St. Rank held Express Scripts Holding Company as of Q4 2018.
Based on Dillon & Associates's 13F filing for Q4 2018, filed 14 Feb 2019.